Searched for
OTC BRANDS
ED case against five Bengaluru-based entities for 'unauthorised' cross-border crypto transactionsThe Enforcement Directorate has initiated a FEMA probe into five companies located in Bengaluru for their alleged involvement in unauthoriz...- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Dabur Q4 Results: Cons PAT rises 15% YoY to Rs 369 crore, revenue up 7%; Rs 5.50 per share dividend announcedDabur India reported robust fourth-quarter earnings growth driven by strong domestic FMCG demand, healthy volume expansion and broad-based ...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Reckitt posts double-digit growth in India business for Q1Reckitt's India operations achieved double-digit growth in the first quarter of 2026. Key brands such as Dettol and Durex performed strongl...
- Piramal Enterprises looks to buy OTC business of Morepen LaboratoriesMorepen has mandated Deloitte Touche Tohmatsu to run a formal process and the negotiations are at quite an advanced stage.
- Dr Reddy's buys 6 OTC brands from US-based Ducere PharmaDr Reddy's will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new ...
- Piramal Enterprises in talks to sell 20% stake in over-the-counter drugs businessThe group is looking to rope in a financial partner to play up its inorganic strategy of acquiring small OTC brands and businesses, said so...
- Piramal Enterprises acquires five OTC brands for Rs 92 croreThe acquisition includes mainly the brands Naturolax, Lactobacil and Farizym, which PEL intends to continue in the Gastro-Intestinal (GI) s...
- Sun Pharma to push Ranbaxy's OTC brands like Revital, Volini, ChericofAccording to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...
- Emami to revive over-the-counter products like Zandu Pancharishta, Nityam ChurnaEmami is reviving its over-the-counter healthcare biz with a slew of brand relaunches along with new distribution system, packaging and mar...
- Piramal gains as Cipla takes precautionThe sale of contraceptive brand I-pill by Cipla to Piramal Healthcare may appear to be a win-win deal for both the companies.
- Piramal buys Cipla's i-pill for Rs 95 crorePiramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter...
- Vitabiotics to launch 3 OTC brands in IndiaUK’s vitamins and health supplements company Vitabiotics is set to launch three of its top over-the-counter brands - Wellman, Wellwoman and...
- GSK eyes nutritional, OTC brands in IndiaGlaxosmithkline (GSK) Consumer Healthcare has announced that it wants to acquire nutritional and over-the-counter (OTC) brands, technologie...
- Pharma majors think small to hit it bigPharma majors are betting big on revenues from ubiquitous local grocers and paan stores in India.
- Paras looks to buy int’l OTC brandsParas Pharmaceuticals iwants to acquire brands, or OTC companies, that would fit in with its growth plans.
Load More
